• Department of Cardiovascular Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, P.R.China;
TIAN Hai, Email: doctor_tianhai@163.com; JIANG Shulin, Email: sljiang36@163.com
Export PDF Favorites Scan Get Citation

With the development of molecular and cellar cardiology, gene therapy to cardiovascular disease has become the hot spot and the direction of study. Now, preclinical studies on ultrasound-mediated gene delivery (UMGD) in cardiovascular disease have achieved some success, but it is still hindered by a series of practical challenges for clinical translation. Even so, UMGD still holds the promise to cardiovascular disease in gene therapy for its non-invasiveness, accuracy, safety and ability to deliver multiple genes with repeated deliveries. In this review, we will focus on the basic principle, the current development, the future prospect and drawbacks of UMGD in the therapeutic applications of cardiovascular disease.

Citation: QIN Xionghai, KANG Kai, SUN Lu, TIAN Hai, JIANG Shulin. The status and prospect of ultrasound and microbubble-mediated gene delivery in cardiovascular disease gene therapy. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2018, 25(3): 256-261. doi: 10.7507/1007-4848.201612044 Copy

  • Previous Article

    Research and application progress of mechanical circulatory support devices for univentricular circulation
  • Next Article

    代谢性疾病外科手术方式的发展及演变